Marla A. Cassidy
FDA investigator
Appears on 2 documents from 2020 to 2026, mostly at sites in North Carolina. Most often cites design and construction features (21 CFR 211.42).
- 2
- Documents on file
- 5.5
- Observations per 483
- 2020
- First seen
- 2026
- Most recent
What they cite most
From 11 observations- 21 CFR 211.42Design and construction features2
- 21 CFR 6061
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.142Warehousing procedures1
Activity by year
2020: 1, 2026: 1
Where
North Carolina 1
Often inspects with
Is Marla A. Cassidy coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2026-03-04 | 483 BioLife Plasma Services L.P.Mar 4, 2026 | — | 1 | |
| 2020-01-24 | 483 Merck Teknika LLCJan 24, 2020 · Durham, North Carolina | Durham, North Carolina | 10 |
About this profile
What does Marla A. Cassidy inspect?
Marla A. Cassidy appears on 2 documents on file covering 2 sites, mostly in North Carolina.
What do they cite most often?
21 CFR 211.42 (design and construction features), followed by 21 CFR 606 and 21 CFR 211.100.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Marla A. Cassidy is dated Mar 4, 2026.